首页 > 市场调查报告书 > 通讯

人工智能

市场调查报告书

商品编码

1727707

人工智慧的共同研究及授权契约:2019年～2025年

Artificial Intelligence (AI) Collaboration and Licensing Deals 2019-2025

出版日期: 2025年05月01日 | 出版商:

Current Partnering | 英文 500+ Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

"人工智慧 (AI) 合作与授权协议" 报告提供了前所未有的途径，让我们能够全面了解全球领先生物製药公司达成的 AI 交易。

这份经过全面修订和更新的报告详细介绍了 2019 年至 2025 年的 AI 交易，并深入分析了企业达成 AI 交易的方式和原因。这些交易通常涉及多个领域，从合作研发到成果商业化。

本报告涵盖了合作、开发、研究和授权交易。

本报告全面列出了自 2019 年以来宣布的 959 笔 AI 交易，包括交易方披露的实际 AI 合作交易的线上交易记录连结以及财务条款（如有）。此外，报告还包含本公司及其合作伙伴向美国证券交易委员会提交的合约文件（如有）。

本报告第一章介绍了人工智慧交易格局。

第一章是对报告的介绍。

第二章概述了自2019年以来的人工智慧交易趋势。

第三章概述了自2019年以来的主要人工智慧交易。交易按交易金额排序。

第四章列出了在人工智慧交易中最活跃的25家公司，并进行了简要总结，随后是完整的人工智慧交易清单以及公开的合约文件。

第五章对自2019年1月以来签署和宣布的人工智慧交易进行了全面深入的回顾，其中的合约文件可在公共领域查阅。

第六章对自2019年1月以来签署和宣布的人工智慧合作交易进行了全面深入的回顾。本章按感兴趣的特定人工智慧技术类型进行组织。

本报告也包含大量图表，展现了2019年及未来的AI交易趋势和活动。

此外，报告还提供了全面的交易目录，按公司A-Z、交易类型和治疗目标进行整理。每个交易标题都透过网页连结连结到线上交易记录，并包含合约文件（如有），方便根据需要轻鬆存取每个合约文件。

主要的优点

"人工智慧 (AI) 合作与授权交易" 为读者提供以下主要优势：

了解 2019 年及以后的交易趋势
浏览 AI 合作与授权交易
基准分析 - 确定交易的市场价值
财务条款 - 一次性付款、里程碑付款、特许权使用费
公司 A-Z、交易类型和治疗领域分类的交易目录
以交易价值排序的热门交易
最活跃的交易撮合者
确定每笔交易的资产和交易条款
存取合约文件 - 深入了解交易结构
尽职调查 - 评估拟议交易条款是否适合您的合作伙伴
节省数百小时的研究时间

调查范围

人工智慧 "合作与授权协议" 旨在深入了解全球领先生物製药公司在人工智慧领域的趋势和交易结构。

人工智慧合作与授权协议包括：

生物製药产业的人工智慧交易趋势
涵盖製药和生物技术领域的人工智慧交易记录目录
主要的人工智慧交易
最活跃的人工智慧授权交易撮合者
"人工智慧合作与授权协议" 提供全面的交易记录，包括合约文件。

分析合约文件有助于对以下内容进行尽职调查：

授予或选择的具体权利是什么？
合约实际上授予了合作公司哪些权利？
授予了哪些独家权利？
合约的付款结构是怎样的？
如何审计销售和付款？
合约期限是多久？
合约的关键条款是如何定义的？
如何处理并拥有知识产权？
谁负责商业化？
谁负责开发、供应和製造？
如何管理保密和资讯揭露？
如何解决争议？
合约在什么情况下可以终止？
如果所有权发生变更会怎样？
双方约定了哪些分授权和分包条款？
公司坚持哪些标准条款？
哪些标准条款似乎因合作伙伴和交易类型的不同而有所差异？
公司在契约法方面主张哪些管辖权？

This report contains a comprehensive listing of 959 artificial intelligence deals announced since 2019 including financial terms where available including links to online deal records of actual artificial intelligence partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of artificial intelligence dealmaking.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in artificial intelligence dealmaking since 2019.

Chapter 3 provides an overview of the leading artificial intelligence deals since 2019. Deals are listed by headline value.

Chapter 4 provides a comprehensive listing of the top 25 most active companies in artificial intelligence dealmaking with a brief summary followed by a comprehensive listing of artificial intelligence deals, as well as contract documents available in the public domain.

Chapter 5 provides a comprehensive and detailed review of artificial intelligence deals signed and announced since Jan 2019, where a contract document is available in the public domain.

Chapter 6 provides a comprehensive and detailed review of artificial intelligence partnering deals signed and announced since Jan 2019. The chapter is organized by specific artificial intelligence technology type in focus.

The report also includes numerous table and figures that illustrate the trends and activities in artificial intelligence deal making since 2019.

In addition, a comprehensive deal directory is provided organized by company A-Z, deal type and therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Key benefits

Artificial Intelligence (AI) Collaboration and Licensing Deals provides the reader with the following key benefits:

Understand deal trends since 2019
Browse artificial intelligence collaboration and licensing deals
Benchmark analysis - identify market value of transactions
Financials terms - upfront, milestone, royalties
Directory of deals by company A-Z, deal type and therapy area
Leading deals by value
Most active dealmakers
Identify assets and deal terms for each transaction
Access contract documents - insights into deal structures
Due diligence - assess suitability of your proposed deal terms for partner companies
Save hundreds of hours of research time

Report scope

Artificial Intelligence (AI) Collaboration and Licensing Deals is intended to provide the reader with an in-depth understanding of artificial intelligence trends and structure of deals entered into by leading biopharma companies worldwide.

Artificial Intelligence (AI) Collaboration and Licensing Deals includes:

Trends in artificial intelligence dealmaking in the biopharma industry
Directory of artificial intelligence deal records covering pharmaceutical and biotechnology
The leading artificial intelligence deals by value
Most active artificial intelligence licensing dealmakers
Artificial Intelligence (AI) Collaboration and Licensing Deals provides comprehensive access to available records for deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

What are the precise rights granted or optioned?
What is actually granted by the agreement to the partner company?
What exclusivity is granted?
What is the payment structure for the deal?
How are sales and payments audited?
What is the deal term?
How are the key terms of the agreement defined?
How are IPRs handled and owned?
Who is responsible for commercialization?
Who is responsible for development, supply, and manufacture?
How is confidentiality and publication managed?
How are disputes to be resolved?
Under what conditions can the deal be terminated?
What happens when there is a change of ownership?
What sublicensing and subcontracting provisions have been agreed?
Which boilerplate clauses does the company insist upon?
Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
Which jurisdiction does the company insist upon for agreement law?

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in artificial intelligence dealmaking

2.1. Introduction
2.2. Artificial intelligence deals over the years
2.3. Most active artificial intelligence dealmakers
2.4. Artificial intelligence deals by deal type
2.5. Artificial intelligence deals by therapy area
2.6. Artificial intelligence deals by industry sector
2.7. Deal terms for artificial intelligence deals
- 2.7.1 Artificial intelligence deals headline values
- 2.7.2 Artificial intelligence deal upfront payments
- 2.7.3 Artificial intelligence deal milestone payments
- 2.7.4 Artificial intelligence royalty rates

Chapter 3 - Leading artificial intelligence deals

3.1. Introduction
3.2. Top artificial intelligence deals by value

Chapter 4 - Most active artificial intelligence dealmakers

4.1. Introduction
4.2. Most active artificial intelligence dealmakers
4.3. Most active artificial intelligence deals company profiles

Chapter 5 - Artificial intelligence contracts dealmaking directory

5.1. Introduction
5.2. Artificial intelligence contracts dealmaking directory

Chapter 6 - Artificial intelligence dealmaking by technology type

Deal directory
Deal directory - Artificial intelligence deals by company A-Z
Deal directory - Artificial intelligence deals by deal type
Deal directory - Artificial intelligence deals by therapy area
Deal type definitions
About Biopharma Research Ltd
Current Partnering
Current Agreements
Recent report titles from Current Partnering

Table of figures

Figure 1: Artificial intelligence deals since 2019
Figure 2: Active artificial intelligence dealmaking activity - 2019 - 2025
Figure 3: Artificial intelligence deals by deal type since 2019
Figure 4: Artificial intelligence deals by therapy area since 2019
Figure 5: Artificial intelligence deals by industry sector since 2019
Figure 6: Artificial intelligence deals with a headline value
Figure 7: Artificial intelligence deals with an upfront value
Figure 8: Artificial intelligence deals with a milestone value
Figure 9: Artificial intelligence deals with a royalty rate value
Figure 10: Top artificial intelligence deals by value since 2019
Figure 11: Most active artificial intelligence dealmakers 2019 - 2025
Figure 12: Artificial intelligence deals by technology type since 2019

02-2729-4219

+886-2-2729-4219

License/价格

人工智慧的共同研究及授权契约:2019年～2025年